resisttb
- Jun 24, 2021
- 1 min read

Shorter treatment regimen found to be effective for treating TB

A research team led by a Medical University of South Carolina (MUSC) investigator reports in the May 6 issue of the New England Journal of Medicine that a four-month treatment regimen using rifapentine is effective for treating TB. Shortening the treatment duration is an important step toward increased patient adherence. Read here

Recent Posts

See All

endTB Trial Redefines Multidrug-Resistant Tuberculosis Treatment Options

Clinical trial results presented for the first time at the Union World Conference on Lung Health revealed evidence to support the use of four new, improved regimens to treat multi-drug resistant tuber

New preventive treatment for children cuts the risk of drug-resistant tuberculosis by more than half

Clinical trial results presented in Paris at the Union World Conference on Lung Health showed that a once-daily dose of a widely available antibiotic over six months cut a child’s risk of developing m

Ending TB Is Within Reach — So Why Are Millions Still Dying?

Tuberculosis, which is preventable and curable, has reclaimed the title of the world’s leading infectious disease killer, after being supplanted from its long reign by Covid-19. But worldwide, 40 perc